| Title: | The role of lifestyle including physical activity, pain, -omics biomarkers and genetics in cardiovascular disease and kidney function |
| Lead Institution: | Karolinska Institutet |
| Principal investigator: | Dr Christoph Nowak |
Application 81508
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Cardiovascular diseases such as stroke and heart attack, and kidney diseases cause significant suffering and early death across the world. Preventing these diseases, including the identification of high-risk groups in the population who might benefit from early interventions, is paramount to improving population health. We aim to study the role of lifestyle factors (such as physical activity), pain (with a focus on chronic pain), so-called biomarkers (small molecules measured in biological samples and fluids), and genes for the occurrence and progression of cardiovascular diseases and kidney diseases. Our main objectives are to identify risk markers that might pinpoint high-risk groups in the population, to identify potential new drug targets for prevention and treatment, and to find factors that causally affect these diseases and might therefore be modified in order to reduce disease risk. The project is expected to last 6 years and is expected to identify new treatment targets and risk markers that can be developed further to reduce morbidity and mortality associated with some of the most common and debilitating diseases in the population, including heart attack, stroke and kidney failure.2 Publications
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 9833 | FEV1 and FVC as robust risk factors for cardiovascular disease and mortality: Insights from a large population study | Andreas Rydell (+4) | 2024 | Respiratory Medicine |
| 11785 | The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank | Per Wändell (+5) | 2024 | BMC Cardiovascular Disorders |
Enabling scientific discoveries that improve human health